WATCH: 23andMe Offers At-Home Test for Breast Cancer Gene Mutations

The DNA testing company 23andMe has gotten FDA approval to screen for 3 BRCA gene mutations linked to a higher risk of breast cancer. But the test raises some concerns. Katie Nielsen of CBS San Francisco station KPIX reports.

SOURCE: CBS News